Learn More
Novex™ Rapamycin
Rapamycin
Brand: Novex™ PHZ1235
Description
Rapamycin is a member of a family of macrolide immunosuppressants that bind to and inhibit the FK506 binding protein (FKBP) proline rotamase.Format/Formulation: Lyophilized

Specifications
Store in freezer (-5 to -30 °C). | |
MTOR | |
mechanistic target of rapamycin (serine/threonine kinase) | |
5 mg | |
914.2 |
2475 | |
FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | |
Wet Ice | |
Rapamycin | |
Solid |
Product Suggestions
Customers who viewed this item also viewed
Safety and Handling
- RAPAMYCIN
Signal Word
- Warning
Hazard Category
- Serious eye damage/eye irritation Category 2
- Germ cell mutagenicity Category 2
- Skin corrosion/irritation Category 2
Hazard Statement
- H315-Causes skin irritation.
- H319-Causes serious eye irritation.
- H341-Suspected of causing genetic defects.
Precautionary Statement
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P321-Specific treatment (see supplemental first aid instructions on this label).
- P405-Store locked up.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental information
- MIXTURE LIST-Contains : Rapamycin
Certificates
A lot number is required to show results for certificates. To find your lot number on previous orders use our order status area.
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
2350295 | Certificate of Analysis | 29/01/2025 | PHZ1235 |
2392309 | Certificate of Analysis | 29/01/2025 | PHZ1235 |
06152138 | Certificate of Analysis | 29/01/2025 | PHZ1235 |
2410494 | Certificate of Analysis | 29/01/2025 | PHZ1235 |
2474111 | Certificate of Analysis | 29/01/2025 | PHZ1235 |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only. Not for use in diagnostic procedures.